References
- Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarström L, Nonoyama S, Quinti I, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59. doi:https://doi.org/10.1016/j.jaip.2015.07.025.
- Maglione PJ, Cols M, Cunningham-Rundles C. Dysregulation of Innate Lymphoid Cells in Common Variable Immunodeficiency. Curr Allergy Asthma Rep. 2017;17(11):77. doi:https://doi.org/10.1007/s11882-017-0746-6.
- Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, Rezaei N, Ochs HD, Aghamohammadi A. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13(2):101–115. doi:https://doi.org/10.1080/1744666X.2016.1224664.
- Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009;145(6):709–727. doi:https://doi.org/10.1111/j.1365-2141.2009.07669.x.
- Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–1657. doi:https://doi.org/10.1182/blood-2011-09-377945.
- Urm S-H, Yun HD, Fenta YA, Yoo KH, Abraham RS, Hagan J, Juhn YJ. Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study. Mayo Clin Proc. 2013;88(8):813–821. doi:https://doi.org/10.1016/j.mayocp.2013.05.021.
- Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM. 2002;95(10):655–662. doi:https://doi.org/10.1093/qjmed/95.10.655.
- Agondi RC, Barros MT, Rizzo LV, Kalil J, Giavina-Bianchi P. Allergic asthma in patients with common variable immunodeficiency. Allergy. 2010;65(4):510–515. doi:https://doi.org/10.1111/j.1398-9995.2009.02211.x.
- Schaffer AA, Salzer U, Hammarstrom L, Grimbacher B. Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev. 2007;17(3):201–212. doi:https://doi.org/10.1016/j.gde.2007.04.002.
- Stary J, Sedlacek P, Vodvarkova S, Gasova Z, Bartunkova J. Development of common variable immunodeficiency in a patient with Evans syndrome treated by autologous stem cell transplantation. Pediatr Allergy Immunol. 2003;14(4):334–337.
- Agondi RC, Barros MT, Kokron CM, Cohon A, Oliveira AKB, Kalil J, Giavina-Bianchi P. Can patients with common variable immunodeficiency have allergic rhinitis? Am J Rhinol Allergy. 2013;27(2):79–83. doi:https://doi.org/10.2500/ajra.2013.27.3855.
- Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2019;123(5):454–460. doi:https://doi.org/10.1016/j.anai.2019.07.014.
- Ho HE, Cunningham-Rundles C. Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis. Front Immunol. 2020;11:149. doi:https://doi.org/10.3389/fimmu.2020.00149.
- Lawrence MG, Palacios-Kibler TV, Workman LJ, Schuyler AJ, Steinke JW, Payne SC, McGowan EC, Patrie J, Fuleihan RL, Sullivan KE, et al. Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID). J Clin Immunol. 2018;38(3):225–233. doi:https://doi.org/10.1007/s10875-018-0476-0.
- Bjelac JA, Blanch MB, Fernandez J. Allergic disease in patients with common variable immunodeficiency at a tertiary care referral center. Ann Allergy Asthma Immunol. 2018;120(1):90–92. doi:https://doi.org/10.1016/j.anai.2017.09.075.
- Schussler E, Beasley MB, Maglione PJ. Lung Disease in Primary Antibody Deficiencies. J Allergy Clin Immunol Pract. 2016;4(6):1039–1052. doi:https://doi.org/10.1016/j.jaip.2016.08.005.
- Pacheco-Gonzalez RM, Avila C, Dávila I, García-Sánchez A, Hernández-Hernández L, Benito-Pescador D, Torres R, Prieto-Matos P, Isidoro-Garcia M, Lorente F, et al. Analysis of FOXP3 gene in children with allergy and autoimmune diseases. Allergol Immunopathol (Madr). 2016;44(1):32–40. doi:https://doi.org/10.1016/j.aller.2015.01.012.
- Georgiev P, Charbonnier LM, Chatila TA. Regulatory T Cells: the Many Faces of Foxp3. J Clin Immunol. 2019;39(7):623–640. doi:https://doi.org/10.1007/s10875-019-00684-7.
- Yao Y-S, Wang L-H, Chang W-W, He L-P, Li J, Jin Y-L, Li C-P. Association between CTLA-4 exon-1 + 49A/G polymorphism and asthma: an updated meta-analysis. Int J Clin Exp Med. 2015;8(3):3107–3113.
- Tachdjian R, Al Khatib S, Schwinglshackl A, Kim HS, Chen A, Blasioli J, Mathias C, Kim HY, Umetsu DT, Oettgen HC, et al. In vivo regulation of the allergic response by the IL-4 receptor alpha chain immunoreceptor tyrosine-based inhibitory motif. J Allergy Clin Immunol. 2010;125(5):1128–1136 e8. doi:https://doi.org/10.1016/j.jaci.2010.01.054.
- Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368(26):2455–2466. doi:https://doi.org/10.1056/NEJMoa1304048.
- Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, Joish VN, Amin N, Maroni J, Rowe P, et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol. 2018;142(1):171–177 e1. doi:https://doi.org/10.1016/j.jaci.2017.11.051.
- Sogkas G, Hirsch S, Jablonka A, Witte T, Schmidt RE, Atschekzei F. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome. Clin Immunol. 2020;215:108452. doi:https://doi.org/10.1016/j.clim.2020.108452.
- Lévy R, Béziat V, Barbieux C, Puel A, Bourrat E, Casanova J-L, Hovnanian A. Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome. J Clin Immunol. 2020;40(2):418–420. doi:https://doi.org/10.1007/s10875-020-00751-4.